The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 8,274,500 | 650,000 | SH | DFND | 1 | 650,000 | 0 | 0 | |
ACCOLADE INC | NOTE 0.500% 4/0 | 00437EAB8 | 107,928,275 | 132,598,000 | PRN | DFND | 1 | 132,598,000 | 0 | 0 | |
ACUTUS MED INC | COM | 005111109 | 1,853,519 | 2,660,808 | SH | DFND | 1 | 2,660,808 | 0 | 0 | |
ADAPTHEALTH CORP | COMMON STOCK | 00653Q102 | 123,832,254 | 13,607,940 | SH | DFND | 1 | 13,607,940 | 0 | 0 | |
ALECTOR INC | COM | 014442107 | 6,837,644 | 1,055,192 | SH | DFND | 1 | 1,055,192 | 0 | 0 | |
ALIGNMENT HEALTHCARE INC | COM | 01625V104 | 19,064,284 | 2,747,015 | SH | DFND | 1 | 2,747,015 | 0 | 0 | |
ANNEXON INC | COM | 03589W102 | 1,378,035 | 583,913 | SH | DFND | 1 | 583,913 | 0 | 0 | |
ARS PHARMACEUTICALS INC | COM | 82835W108 | 41,874,564 | 11,077,927 | SH | DFND | 1 | 11,077,927 | 0 | 0 | |
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 9,015,448 | 448,753 | SH | DFND | 1 | 448,753 | 0 | 0 | |
BIO RAD LABS INC | CL A | 090572207 | 62,351,302 | 173,947 | SH | DFND | 1 | 173,947 | 0 | 0 | |
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 23,264,880 | 3,286,000 | SH | DFND | 1 | 3,286,000 | 0 | 0 | |
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 2,670,383 | 930,447 | SH | DFND | 1 | 930,447 | 0 | 0 | |
BROOKDALE SR LIVING INC | COM | 112463104 | 52,493,755 | 12,679,651 | SH | DFND | 1 | 12,679,651 | 0 | 0 | |
BROOKDALE SR LIVING INC | NOTE 2.000%10/1 | 112463AC8 | 114,346,109 | 145,955,000 | PRN | DFND | 1 | 145,955,000 | 0 | 0 | |
BUTTERFLY NETWORK INC | *W EXP 02/12/202 | 124155110 | 48,547 | 733,333 | SH | DFND | 1 | 733,333 | 0 | 0 | |
CABALETTA BIO INC | COM | 12674W109 | 35,616,596 | 2,340,118 | SH | DFND | 1 | 2,340,118 | 0 | 0 | |
CAREMAX INC | COM CL A | 14171W103 | 33,651,212 | 15,873,213 | SH | DFND | 1 | 15,873,213 | 0 | 0 | |
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 134,400 | 672,000 | SH | DFND | 1 | 672,000 | 0 | 0 | |
CARIBOU BIOSCIENCES INC | COM | 142038108 | 16,730,000 | 3,500,000 | SH | DFND | 1 | 3,500,000 | 0 | 0 | |
CASTLE BIOSCIENCES INC | COM | 14843C105 | 15,988,412 | 946,620 | SH | DFND | 1 | 946,620 | 0 | 0 | |
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 95,764,480 | 8,192,000 | SH | DFND | 1 | 8,192,000 | 0 | 0 | |
CENTENE CORP DEL | COM | 15135B101 | 137,071,200 | 1,990,000 | SH | DFND | 1 | 1,990,000 | 0 | 0 | |
COGENT BIOSCIENCES INC | COM | 19240Q201 | 10,621,114 | 1,089,345 | SH | DFND | 1 | 1,089,345 | 0 | 0 | |
CUTERA INC | COM | 232109108 | 929,524 | 154,406 | SH | DFND | 1 | 154,406 | 0 | 0 | |
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 15,582,802 | 1,269,992 | SH | DFND | 1 | 1,269,992 | 0 | 0 | |
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 87,737,548 | 6,897,606 | SH | DFND | 1 | 6,897,606 | 0 | 0 | |
DENALI THERAPEUTICS INC | COM | 24823R105 | 12,274,623 | 594,989 | SH | DFND | 1 | 594,989 | 0 | 0 | |
DISC MEDICINE INC | COM | 254604101 | 20,201,400 | 430,000 | SH | DFND | 1 | 430,000 | 0 | 0 | |
DOCGO INC | COM | 256086109 | 25,392,120 | 4,764,000 | SH | DFND | 1 | 4,764,000 | 0 | 0 | |
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 22,536,875 | 3,933,137 | SH | DFND | 1 | 3,933,137 | 0 | 0 | |
ENHABIT INC | COM | 29332G102 | 56,224,643 | 4,997,746 | SH | DFND | 1 | 4,997,746 | 0 | 0 | |
FOGHORN THERAPEUTICS INC | COM | 344174107 | 3,887,625 | 777,525 | SH | DFND | 1 | 777,525 | 0 | 0 | |
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 7,339,800 | 2,823,000 | SH | DFND | 1 | 2,823,000 | 0 | 0 | |
GENEDX HOLDINGS CORP | COM CL A | 81663L200 | 4,564,178 | 1,253,895 | SH | DFND | 1 | 1,253,895 | 0 | 0 | |
GLAUKOS CORP | NOTE 2.750% 6/1 | 377322AB8 | 426,548,000 | 271,452,000 | PRN | DFND | 1 | 271,452,000 | 0 | 0 | |
GUARDANT HEALTH INC | COM | 40131M109 | 39,419,273 | 1,329,935 | SH | DFND | 1 | 1,329,935 | 0 | 0 | |
HEALTH CATALYST INC | NOTE 2.500% 4/1 | 42225TAB3 | 28,517,130 | 30,000,000 | PRN | DFND | 1 | 30,000,000 | 0 | 0 | |
HILLEVAX INC | COM | 43157M102 | 53,856,907 | 4,004,231 | SH | DFND | 1 | 4,004,231 | 0 | 0 | |
IDEAYA BIOSCIENCES INC | COM | 45166A102 | 61,207,583 | 2,268,628 | SH | DFND | 1 | 2,268,628 | 0 | 0 | |
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 107,555,623 | 108,858,000 | PRN | DFND | 1 | 108,858,000 | 0 | 0 | |
INSULET CORP | COM | 45784P101 | 20,255,230 | 127,000 | SH | DFND | 1 | 127,000 | 0 | 0 | |
INTEGRA LIFESCIENCES HLDGS C | COM NEW | 457985208 | 43,033,523 | 1,126,827 | SH | DFND | 1 | 1,126,827 | 0 | 0 | |
INTERCEPT PHARMACEUTICALS IN | COM | 45845P108 | 38,524,136 | 2,077,893 | SH | DFND | 1 | 2,077,893 | 0 | 0 | |
INTERCEPT PHARMACEUTICALS IN | NOTE 3.500% 2/1 | 45845PAC2 | 105,134,820 | 98,354,000 | PRN | DFND | 1 | 98,354,000 | 0 | 0 | |
INVITAE CORP | DEBT 4.500% 3/1 | 46185LAH6 | 163,823,402 | 217,766,000 | PRN | DFND | 1 | 217,766,000 | 0 | 0 | |
ITEOS THERAPEUTICS INC | COM | 46565G104 | 7,916,850 | 723,000 | SH | DFND | 1 | 723,000 | 0 | 0 | |
KURA ONCOLOGY INC | COM | 50127T109 | 39,891,281 | 4,374,044 | SH | DFND | 1 | 4,374,044 | 0 | 0 | |
LARIMAR THERAPEUTICS INC | COM | 517125100 | 66,918,360 | 16,941,357 | SH | DFND | 1 | 16,941,357 | 0 | 0 | |
LIVONGO HEALTH INC | NOTE 0.875% 6/0 | 539183AA1 | 45,665,200 | 50,000,000 | PRN | DFND | 1 | 50,000,000 | 0 | 0 | |
MEDAVAIL HOLDINGS INC | COM NEW | 58406B202 | 100,392 | 16,732 | SH | DFND | 1 | 16,732 | 0 | 0 | |
MERUS N V | COM | N5749R100 | 91,418,198 | 3,876,938 | SH | DFND | 1 | 3,876,938 | 0 | 0 | |
NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 53,000,791 | 70,204,000 | PRN | DFND | 1 | 70,204,000 | 0 | 0 | |
NATERA INC | NOTE 2.250% 5/0 | 632307AB0 | 133,525,487 | 101,042,000 | PRN | DFND | 1 | 101,042,000 | 0 | 0 | |
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 5,994,495 | 6,500,000 | PRN | DFND | 1 | 6,500,000 | 0 | 0 | |
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 136,092,825 | 1,209,714 | SH | DFND | 1 | 1,209,714 | 0 | 0 | |
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 176,295 | 92,787 | SH | DFND | 1 | 92,787 | 0 | 0 | |
NUVALENT INC | COM | 670703107 | 918,987,373 | 19,991,024 | SH | DFND | 1 | 19,991,024 | 0 | 0 | |
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 16,667 | 166,666 | SH | DFND | 1 | 166,666 | 0 | 0 | |
NYXOAH S A | SHS | B6S7WD106 | 2,821,805 | 400,256 | SH | DFND | 1 | 400,256 | 0 | 0 | |
ORCHARD THERAPEUTICS PLC | SPON ADS NEW | 68570P200 | 2,443,986 | 316,169 | SH | DFND | 1 | 316,169 | 0 | 0 | |
OWENS & MINOR INC NEW | COM | 690732102 | 103,989,600 | 6,435,000 | SH | DFND | 1 | 6,435,000 | 0 | 0 | |
PRIME MEDICINE INC | COM | 74168J101 | 8,445,896 | 885,314 | SH | DFND | 1 | 885,314 | 0 | 0 | |
PTC THERAPEUTICS INC | NOTE 1.500% 9/1 | 69366JAD3 | 17,509,030 | 22,000,000 | PRN | DFND | 1 | 22,000,000 | 0 | 0 | |
PULMONX CORP | COM | 745848101 | 10,515,506 | 1,017,958 | SH | DFND | 1 | 1,017,958 | 0 | 0 | |
QUANTUM SI INC | *W EXP 06/10/202 | 74765K113 | 90,000 | 333,333 | SH | DFND | 1 | 333,333 | 0 | 0 | |
QUIDELORTHO CORP | COM | 219798105 | 10,956,000 | 150,000 | SH | DFND | 1 | 150,000 | 0 | 0 | |
RAYZEBIO INC | COM | 75525N107 | 25,732,597 | 1,159,126 | SH | DFND | 1 | 1,159,126 | 0 | 0 | |
REVANCE THERAPEUTICS INC | COM | 761330109 | 9,978,900 | 870,000 | SH | DFND | 1 | 870,000 | 0 | 0 | |
REVOLUTION MEDICINES INC | COM | 76155X100 | 48,481,409 | 1,751,496 | SH | DFND | 1 | 1,751,496 | 0 | 0 | |
ROIVANT SCIENCES LTD | SHS | G76279101 | 18,740,408 | 1,604,487 | SH | DFND | 1 | 1,604,487 | 0 | 0 | |
SIENTRA INC | COM | 82621J204 | 27,800 | 10,000 | SH | DFND | 1 | 10,000 | 0 | 0 | |
SINGULAR GENOMICS SYSTEMS IN | COM | 82933R100 | 1,899,236 | 4,984,871 | SH | DFND | 1 | 4,984,871 | 0 | 0 | |
SOMALOGIC INC | *W EXP 08/31/202 | 83444K113 | 26,412 | 120,000 | SH | DFND | 1 | 120,000 | 0 | 0 | |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 36,519,751 | 1,579,574 | SH | DFND | 1 | 1,579,574 | 0 | 0 | |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | 31,654,331 | 627,813 | SH | DFND | 1 | 627,813 | 0 | 0 | |
SURGERY PARTNERS INC | COM | 86881A100 | 42,705,000 | 1,460,000 | SH | DFND | 1 | 1,460,000 | 0 | 0 | |
SURROZEN INC | *W EXP 08/01/203 | 86889P117 | 6,850 | 166,666 | SH | DFND | 1 | 166,666 | 0 | 0 | |
TABULA RASA HEALTHCARE INC | NOTE 1.750% 2/1 | 873379AA9 | 141,534,635 | 144,516,000 | PRN | DFND | 1 | 144,516,000 | 0 | 0 | |
TANGO THERAPEUTICS INC | COM | 87583X109 | 8,937,389 | 793,729 | SH | DFND | 1 | 793,729 | 0 | 0 | |
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 13,399,326 | 754,042 | SH | DFND | 1 | 754,042 | 0 | 0 | |
THE ONCOLOGY INSTITUTE INC | COM | 68236X100 | 4,704,073 | 3,360,052 | SH | DFND | 1 | 3,360,052 | 0 | 0 | |
THE ONCOLOGY INSTITUTE INC | *W EXP 11/15/202 | 68236X118 | 114,875 | 1,250,000 | SH | DFND | 1 | 1,250,000 | 0 | 0 | |
TRISALUS LIFE SCIENCES INC | *W EXP 08/10/202 | 89680M119 | 126,667 | 333,333 | SH | DFND | 1 | 333,333 | 0 | 0 | |
TRISALUS LIFE SCIENCES INC | COM | 89680M101 | 5 | 1 | SH | DFND | 1 | 1 | 0 | 0 | |
VERASTEM INC | COM NEW | 92337C203 | 12,507,688 | 1,538,461 | SH | DFND | 1 | 1,538,461 | 0 | 0 | |
VIATRIS INC | COM | 92556V106 | 195,853,962 | 19,863,485 | SH | DFND | 1 | 19,863,485 | 0 | 0 | |
VIGIL NEUROSCIENCE INC | COM | 92673K108 | 9,849,686 | 1,827,400 | SH | DFND | 1 | 1,827,400 | 0 | 0 | |
VIKING THERAPEUTICS INC | COM | 92686J106 | 14,158,530 | 1,279,000 | SH | DFND | 1 | 1,279,000 | 0 | 0 |